Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-04), Neuberger Berman High Yield Strategies Fund's 3-1 Month Momentum % is -4.31%.
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Neuberger Berman High Yield Strategies Fund 3-1 Month Momentum % Related Terms
NHS vs CPZ, JRS, NUW: 3-1 Month Momentum % Comparison
For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuberger Berman High Yield Strategies Fund 3-1 Month Momentum % vs Asset Management Industry
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuberger Berman High Yield Strategies Fund (NHS) has a 3-1 Month Momentum % of -4.31% as of Aug. 04, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1118 out of 1639 companies in the Asset Management industry, placing it in the top 68.2%.
Is Neuberger Berman High Yield Strategies Fund's 3-1 Month Momentum % too high?
Neuberger Berman High Yield Strategies Fund's current 3-1 Month Momentum % is -4.31%. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1118 out of 1639 companies in the Asset Management industry, which is below the industry midpoint. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's 3-1 Month Momentum % compare to CPZ and JRS?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #1118 out of 1639 companies for 3-1 Month Momentum %. This places Neuberger Berman High Yield Strategies Fund in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for an Asset Management company?
A good 3-1 Month Momentum % depends on the Asset Management industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. Neuberger Berman High Yield Strategies Fund's current 3-1 Month Momentum % is -4.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.06 — trading 16.2% below its estimated fair value. The current 3-1 Month Momentum % is -4.31%. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current 3-1 Month Momentum % is -4.31% as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued.
The current stock price of $6.06 is trading 16.2% below its estimated GF Value™ of $7.23.
GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.
Key valuation signals for NHS:
3-1 Month Momentum %: -4.31%
GF Value™: $7.23 vs. price of $6.06 (16.2% below fair value)
No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score
Get the complete analysis for NHS
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHS has been successfully added to your 
